Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec 6:10:851.
doi: 10.3389/fendo.2019.00851. eCollection 2019.

Editorial: Metformin: Beyond Diabetes

Frédéric Bost  1 , Graham Rena  2 , Benoit Viollet  3
Affiliations
Editorial

Editorial: Metformin: Beyond Diabetes

Frédéric Bost et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: PCOS (polycystic ovarian syndrome); cancer; diabetes; gut microbiota; metformin; mitochondria; neurodegenerative disease.

PubMed Disclaimer

Comment on

  • Editorial on the Research Topic Metformin: Beyond Diabetes

References

    1. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem. (2000) 275:223–8. 10.1074/jbc.275.1.223 - DOI - PubMed
    1. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. (2000) 348(Pt 3), 607–614. 10.1042/bj3480607 - DOI - PMC - PubMed
    1. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. (2001) 108:1167–74. 10.1172/JCI13505 - DOI - PMC - PubMed
    1. Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. (2019) 15:569–89. 10.1038/s41574-019-0242-2 - DOI - PubMed
    1. Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, et al. . Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. (2010) 120:2355–69. 10.1172/JCI40671 - DOI - PMC - PubMed

Publication types

LinkOut - more resources